recombin
sever
acut
respiratori
syndrom
sar
nucleocapsid
spike
proteinbas
immunoglobulin
g
immunoassay
develop
evalu
assay
demonstr
high
sensit
specif
sar
coronaviru
sera
collect
patient
late
year
postonset
symptom
assay
use
routin
sar
coronaviru
diagnost
also
epidemiolog
antibodi
kinet
studi
outbreak
sever
acut
respiratori
syndrom
sar
last
fewer
month
yet
major
impact
public
health
socioeconom
sinc
end
sar
outbreak
identifi
sarsassoci
coronaviru
sarscov
infect
direct
laboratori
exposur
result
commun
transmiss
seven
individu
sporad
communityacquir
infect
sinc
addit
case
may
occur
could
undetect
quickli
lead
anoth
global
outbreak
import
continu
improv
abil
reliabl
monitor
sarscov
infect
coronavirus
spike
nucleocapsid
n
protein
abundantli
express
viru
infect
effect
among
coronaviru
structur
protein
induc
antibodi
respons
previou
studi
demonstr
util
antin
anti
protein
diagnosi
sarscov
infect
studi
describ
evalu
comparison
recombin
spike
nucleocapsid
enzymelink
immunosorb
assay
elisa
specif
detect
sarscov
infect
recombin
fulllength
sar
n
gene
amplifi
sarscov
rna
urbani
strain
modifi
contain
ctermin
tag
clone
venezuelan
equin
enceph
viru
replicon
vector
babi
hamster
kidney
bhk
cell
transfect
sar
n
replicon
rna
electropor
cell
harvest
express
protein
purifi
metal
affin
chromatographi
analyz
silver
stain
western
blot
analysi
appropri
size
immunoreact
protein
control
antigen
nontox
ctermin
fragment
botulinum
neurotoxin
serotyp
bonthca
express
describ
solubl
codonoptim
sarscov
glycoprotein
kda
amino
acid
control
antigen
truncat
angiotensinconvert
enzym
kda
glycosyl
clone
mychi
express
cell
protein
purifi
use
metalaffin
chromatographi
analyz
describ
babcock
et
al
recombin
sar
n
protein
indirect
elisa
develop
use
modifi
version
inactiv
wholeviru
elisa
describ
ksiazek
et
al
briefli
elisa
plate
immulon
coat
either
purifi
recombin
n
protein
ngwell
control
antigen
bont
hca
purifi
cmyctag
recombin
protein
elisa
condit
optim
use
antibodyposit
neg
serum
specimen
result
assay
evalu
use
avail
serum
sampl
collect
patient
vietnam
taiwan
laboratoryconfirm
sarscov
infect
day
postonset
symptom
dpo
us
patient
nonsarsrel
respiratori
infect
healthi
us
donor
exposur
sarscov
addit
serum
sampl
collect
nonsar
patient
vietnam
taiwan
specimen
use
studi
exempt
cdc
institut
review
board
review
cfr
b
elisa
result
repres
serum
specimen
patient
sar
healthi
control
shown
fig
sum
mean
absorb
valu
healthi
control
three
time
standard
deviat
n
protein
assay
respect
cutoff
valu
serum
sampl
healthi
donor
absorb
valu
cutoff
valu
n
protein
elisa
sampl
cutoff
protein
elisa
result
specif
n
protein
elisa
respect
tabl
control
sampl
reactiv
either
n
protein
show
reactiv
altern
protein
also
show
reactiv
inactiv
sarscov
lysat
elisa
sampl
reactiv
may
due
nonspecif
reactiv
crossreact
antibodi
evalu
specif
assay
avail
sera
individu
infect
nonsarsrel
respiratori
virus
includ
human
coronaviru
strain
n
pair
specimen
n
pair
specimen
respiratori
syncyti
viru
n
human
parainfluenza
viru
n
n
influenza
b
viru
n
adenoviru
n
mump
viru
n
analyz
none
serum
sampl
posit
either
assay
data
shown
addit
serum
sampl
nonsar
patient
taiwan
vietnam
show
reactiv
either
assay
data
shown
sera
sar
case
antibodi
posit
n
protein
posit
protein
two
acutephas
specimen
dpo
weakli
reactiv
protein
fell
assay
cutoff
also
posit
immunofluoresc
antibodi
test
elisa
use
whole
gammairradi
sarscov
antigen
data
shown
sensit
n
protein
assay
respect
persist
level
sarscov
igg
detect
sar
case
sever
month
year
diseas
onset
studi
serum
sampl
sar
patient
vietnam
unit
state
collect
day
day
day
onset
ill
test
presenc
sarscovand
nand
sproteinspecif
igg
elisa
antibodi
igg
specif
whole
viru
n
protein
protein
detect
sampl
test
respect
interestingli
antisarscov
antibodi
detect
three
patient
two
also
demonstr
respons
n
protein
almost
year
postonset
symptom
sar
titer
n
n
protein
titer
n
protein
titer
n
evalu
elisa
illustr
valu
sever
assay
system
detect
confirm
sarscov
infect
although
serum
specimen
unexpos
person
test
posit
sarscov
infect
potenti
crossreact
sarscov
coronavirus
includ
known
human
coronavirus
recent
identifi
remain
concern
whether
posit
result
due
nonspecif
reactiv
recombin
sar
n
protein
crossreact
human
cov
requir
studi
use
protein
fragment
peptid
instead
whole
recombin
n
protein
antibodi
detect
may
resolv
issu
potenti
crossreact
protein
human
cov
focu
studi
fals
posit
could
present
public
health
dilemma
illustr
laboratori
evalu
four
sporad
case
report
liang
et
al
case
necessari
conduct
confirmatori
test
use
sever
differ
type
assay
concern
data
studi
suggest
combin
assay
may
need
confirm
specif
presum
sar
antibodi
sinc
cost
ie
public
health
intervent
outbreak
respons
detect
falseposit
result
detect
case
sarscov
infect
high
import
wellcharacter
detect
confirmatori
assay
absenc
virusspecif
control
measur
eg
vaccin
antivir
drug
key
control
reemerg
sar
rapid
diagnosi
implement
infect
control
measur
ie
isol
case
identifi
manag
contact
prevent
transmiss
develop
wellcharacter
detect
confirmatori
serolog
test
key
laboratori
diagnost
support
sar
reemerg
two
elisa
use
compon
sar
diagnost
system
assay
also
use
studi
kinet
proteinspecif
sar
antibodi
respons
help
character
sar
immun
pathogenesi
diseas
thank
deryuan
wang
bureau
food
drug
analysi
depart
health
taiwan
republ
china
meiy
w
yu
cberfood
drug
administr
bethesda
md
lich
hsu
center
diseas
control
depart
health
taiwan
republ
china
provid
panel
sera
sar
patient
thank
also
ann
falsey
univers
rochest
school
medicin
rochest
ny
dean
erdman
cdc
atlanta
ga
provid
sera
patient
nonsarsrel
respiratori
infect
debi
cannon
cdc
atlanta
ga
technic
assist
find
conclus
report
author
necessarili
repres
view
cdc
